Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3551
Eton Pharmaceutcials
ETON
$1.58B
| $653K | ﹤0.01% |
45,790
+1,129
| +3% | +$17.8K |
2024 Q4
2 quarters
|
|
3552
International Money Express
IMXI
$354M
| $650K | ﹤0.01% |
64,468
+9,627
| +18% | +$110K |
2019 Q1
25 quarters
|
|
3553
Mayville Engineering Co
MEC
$426M
| $646K | ﹤0.01% |
40,502
+10,865
| +37% | +$155K |
2019 Q2
24 quarters
|
|
3554
Simulations Plus
SLP
$374M
| $646K | ﹤0.01% |
37,008
+15,393
| +71% | +$432K |
2023 Q1
9 quarters
|
|
3555
Velocity Financial
VEL
$582M
| $642K | ﹤0.01% |
34,616
+19,480
| +129% | +$341K |
2022 Q1
13 quarters
|
|
|
NESR
3556
National Energy Services Reunited Corp
NESR
$2.48B
| $640K | ﹤0.01% |
106,234
+69,324
| +188% | +$430K |
2024 Q4
2 quarters
|
|
|
KRMN
3557
Karman Holdings
KRMN
$4.37B
| $639K | ﹤0.01% |
+12,691
| New | +$511K |
2025 Q2
0 quarters
|
|
3558
Aehr Test Systems
AEHR
$3.49B
| $638K | ﹤0.01% |
49,343
+18,536
| +60% | +$176K |
2022 Q3
11 quarters
|
|
3559
Urban One Class D
UONEK
$16.4M
| $637K | ﹤0.01% |
100,020
+14,896
| +17% | +$89.1K |
2021 Q1
17 quarters
|
|
3560
Anterix
ATEX
$1.64B
| $636K | ﹤0.01% |
24,812
-8,309
| -25% | -$243K |
2022 Q1
13 quarters
|
|
3561
Critical Metals Corp
CRML
$1.07B
| $636K | ﹤0.01% |
177,673
+146,936
| +478% | +$268K |
2024 Q2
4 quarters
|
|
3562
Brady Corp
BRC
$4.04B
| $636K | ﹤0.01% |
9,357
-5,787
| -38% | -$403K |
2016 Q1
37 quarters
|
|
3563
Intrepid Potash
IPI
$447M
| $636K | ﹤0.01% |
17,799
+6,791
| +62% | +$232K |
2022 Q1
13 quarters
|
|
3564
Movado Group
MOV
$748M
| $636K | ﹤0.01% |
41,675
+24,874
| +148% | +$380K |
2016 Q1
37 quarters
|
|
3565
Jack in the Box
JACK
$237M
| $634K | ﹤0.01% |
36,321
+7,926
| +28% | +$178K |
2013 Q2
48 quarters
|
|
|
PHLT
3566
DELISTED
Performant Healthcare Inc
PHLT
| $634K | ﹤0.01% |
158,511
+69,046
| +77% | +$196K |
2023 Q2
8 quarters
|
|
3567
Riley Exploration Permian
REPX
$959M
| $634K | ﹤0.01% |
24,170
+10,625
| +78% | +$281K |
2022 Q1
13 quarters
|
|
3568
NVE Corp
NVEC
$548M
| $630K | ﹤0.01% |
8,562
+3,356
| +64% | +$222K |
2022 Q3
11 quarters
|
|
|
ATXS
3569
DELISTED
Astria Therapeutics
ATXS
| $630K | ﹤0.01% |
117,534
+44,901
| +62% | +$218K |
2023 Q1
9 quarters
|
|
3570
Fidelity D&D Bancorp
FDBC
$323M
| $630K | ﹤0.01% |
13,685
+4,234
| +45% | +$174K |
2018 Q2
28 quarters
|
|
3571
CALL
Norwegian Cruise Line
NCLH
$6.86B
| $629K | ﹤0.01% |
31,000
-307,400
| -91% | -$5.5M |
2023 Q3
7 quarters
|
|
3572
Compass Therapeutics
CMPX
$178M
| $628K | ﹤0.01% |
241,721
+122,990
| +104% | +$254K |
2022 Q3
11 quarters
|
|
3573
Vaalco Energy
EGY
$616M
| $626K | ﹤0.01% |
173,486
+44,927
| +35% | +$156K |
2022 Q2
12 quarters
|
|
|
CTEV
3574
Claritev Corp
CTEV
$395M
| $625K | ﹤0.01% |
+13,849
| New | +$398K |
2025 Q2
0 quarters
|
|
3575
Greenlight Captial
GLRE
$482M
| $625K | ﹤0.01% |
43,476
+16,211
| +59% | +$223K |
2013 Q4
46 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.